BIOMAT Database Logo BIOMAT Database Logo

Synthesis and pharmacological evaluation of dimer derivatives of the bradykinin receptor antagonist HOE-140. 1998

I Daffix, and M Amblard, and G Bergé, and P Dodey, and D Pruneau, and J L Paquet, and C Fouchet, and R M Franck, and E Defrêne, and J M Luccarini, and P Bélichard, and J Martinez
Laboratoire des Aminoacides Peptides et Protéines, UMR CNRS 5810, Université de Montpellier I, Faculté de Pharmacie, France.

The synthesis and pharmacological evaluation of dimer derivatives of the C-terminal fragments of the potent bradykinin antagonist HOE-140, linked through their N-termini, were performed. The influence of peptide moiety length was studied using the succinyl moiety as a linker. Our attention focused on the dimer of the C-terminal tetrapeptide of HOE-140 (compound JMV 980), which displayed some inhibiting activity (IC50 = 247 nM) for bradykinin B2 receptors. Unexpectedly, it was orally active in inhibiting bradykinin-induced hypotension in the rat. Based on this tetrapeptide dimer model, we synthesized pseudotetrapeptide dimer bradykinin antagonists 29 and 33, which exhibited high affinity (Ki = 76 and 61 nM, respectively) for the human cloned B2 receptor. In addition, compound 29 inhibited bradykinin-induced contraction of the human umbilical vein giving a pKB value of 6.45. Compounds 29 and 33 were selective toward B2 receptors because they did not bind to the cloned human B1 receptor up to 10 microM.

UI MeSH Term Description Entries
D009119 Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. Inotropism,Muscular Contraction,Contraction, Muscle,Contraction, Muscular,Contractions, Muscle,Contractions, Muscular,Inotropisms,Muscle Contractions,Muscular Contractions
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D001920 Bradykinin A nonapeptide messenger that is enzymatically produced from KALLIDIN in the blood where it is a potent but short-lived agent of arteriolar dilation and increased capillary permeability. Bradykinin is also released from MAST CELLS during asthma attacks, from gut walls as a gastrointestinal vasodilator, from damaged tissues as a pain signal, and may be a neurotransmitter. Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg,Bradykinin Acetate, (9-D-Arg)-Isomer,Bradykinin Diacetate,Bradykinin Hydrochloride,Bradykinin Triacetate,Bradykinin, (1-D-Arg)-Isomer,Bradykinin, (2-D-Pro)-Isomer,Bradykinin, (2-D-Pro-3-D-Pro-7-D-Pro)-Isomer,Bradykinin, (2-D-Pro-7-D-Pro)-Isomer,Bradykinin, (3-D-Pro)-Isomer,Bradykinin, (3-D-Pro-7-D-Pro)-Isomer,Bradykinin, (5-D-Phe)-Isomer,Bradykinin, (5-D-Phe-8-D-Phe)-Isomer,Bradykinin, (6-D-Ser)-Isomer,Bradykinin, (7-D-Pro)-Isomer,Bradykinin, (8-D-Phe)-Isomer,Bradykinin, (9-D-Arg)-Isomer,Arg Pro Pro Gly Phe Ser Pro Phe Arg
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D043782 Receptor, Bradykinin B2 A constitutively expressed subtype of bradykinin receptor that may play a role in the acute phase of the inflammatory and pain response. It has high specificity for intact forms of BRADYKININ and KALLIDIN. The receptor is coupled to G-PROTEIN, GQ-G11 ALPHA FAMILY and G-PROTEIN, GI-GO ALPHA FAMILY signaling proteins. Bradykinin B2 Receptor,Bradykinin Type 2 Receptor,Bradykinin B2 Receptors,Receptor, Bradykinin Type 2,B2 Receptor, Bradykinin,B2 Receptors, Bradykinin,Receptors, Bradykinin B2
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

I Daffix, and M Amblard, and G Bergé, and P Dodey, and D Pruneau, and J L Paquet, and C Fouchet, and R M Franck, and E Defrêne, and J M Luccarini, and P Bélichard, and J Martinez
Synthesis and analysis of potent, more lipophilic derivatives of the bradykinin B2 receptor antagonist peptide Hoe 140.
April 2002, The journal of peptide research : official journal of the American Peptide Society,
I Daffix, and M Amblard, and G Bergé, and P Dodey, and D Pruneau, and J L Paquet, and C Fouchet, and R M Franck, and E Defrêne, and J M Luccarini, and P Bélichard, and J Martinez
Pharmacological and molecular actions of the bradykinin B2 receptor antagonist, Hoe 140, in the rat uterus.
April 1993, European journal of pharmacology,
I Daffix, and M Amblard, and G Bergé, and P Dodey, and D Pruneau, and J L Paquet, and C Fouchet, and R M Franck, and E Defrêne, and J M Luccarini, and P Bélichard, and J Martinez
DesArg10[Hoe 140] is a potent B1 bradykinin antagonist.
January 1992, Agents and actions. Supplements,
I Daffix, and M Amblard, and G Bergé, and P Dodey, and D Pruneau, and J L Paquet, and C Fouchet, and R M Franck, and E Defrêne, and J M Luccarini, and P Bélichard, and J Martinez
A specific B2-bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramipril.
April 1992, British journal of pharmacology,
I Daffix, and M Amblard, and G Bergé, and P Dodey, and D Pruneau, and J L Paquet, and C Fouchet, and R M Franck, and E Defrêne, and J M Luccarini, and P Bélichard, and J Martinez
Effects of the bradykinin antagonist, HOE 140, in experimental acute pancreatitis.
October 1992, British journal of pharmacology,
I Daffix, and M Amblard, and G Bergé, and P Dodey, and D Pruneau, and J L Paquet, and C Fouchet, and R M Franck, and E Defrêne, and J M Luccarini, and P Bélichard, and J Martinez
Differential sensitivity of antinociceptive assays to the bradykinin antagonist Hoe 140.
January 1993, British journal of pharmacology,
I Daffix, and M Amblard, and G Bergé, and P Dodey, and D Pruneau, and J L Paquet, and C Fouchet, and R M Franck, and E Defrêne, and J M Luccarini, and P Bélichard, and J Martinez
The effect of bradykinin and the bradykinin antagonist Hoe 140 on kinematic parameters of human spermatozoa.
June 1996, International journal of andrology,
I Daffix, and M Amblard, and G Bergé, and P Dodey, and D Pruneau, and J L Paquet, and C Fouchet, and R M Franck, and E Defrêne, and J M Luccarini, and P Bélichard, and J Martinez
Cellular distribution and fate of the bradykinin antagonist HOE 140 in the rat kidney. Colocalization with the bradykinin B2 receptor.
June 1996, Immunopharmacology,
I Daffix, and M Amblard, and G Bergé, and P Dodey, and D Pruneau, and J L Paquet, and C Fouchet, and R M Franck, and E Defrêne, and J M Luccarini, and P Bélichard, and J Martinez
Renal haemodynamic effects of B2 receptor agonist bradykinin and B2 receptor antagonist HOE 140 in conscious lambs.
November 2000, Experimental physiology,
I Daffix, and M Amblard, and G Bergé, and P Dodey, and D Pruneau, and J L Paquet, and C Fouchet, and R M Franck, and E Defrêne, and J M Luccarini, and P Bélichard, and J Martinez
Pharmacological characterization of a new highly potent B2 receptor antagonist (HOE 140: D-Arg-[Hyp3,Thi5,D-Tic7,Qic8]bradykinin).
January 1992, European journal of pharmacology,
Copied contents to your clipboard!